Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
16.64
+0.78 (4.92%)
At close: Jun 18, 2026, 4:00 PM EDT
16.80
+0.16 (0.96%)
After-hours: Jun 18, 2026, 7:45 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Surgical & Medical Equipment
8.65M8.19M6.71M23.54M4.43M
Surgical & Medical Equipment Growth
5.64%21.95%-71.49%431.67%-
Total
8.65M8.19M6.71M23.54M4.43M
Total Growth
5.64%21.95%-71.49%431.67%-

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
European Union
5.15M5.62M4.66M20.30M4.09M
European Union Growth
-8.31%20.54%-77.04%396.27%-
Asia Pacific
1.52M509.17K73.40K3.19M-
Asia Pacific Growth
198.61%593.74%-97.70%--
North America
296.20K110.51K215.44K50.00K337.50K
North America Growth
168.03%-48.71%330.87%-85.19%-
South America
269.54K1.48M1.65M--
South America Growth
-81.73%-10.68%---
Other Regions
1.41M472.38K111.05K--
Other Regions Growth
198.40%325.38%---
Total
8.65M8.19M6.71M23.54M4.43M
Total Growth
5.64%21.95%-71.49%431.67%-